, Tracking Stock Market Picks
Enter Symbol:

up 770.35 %

PHARMASSET INC. (VRUS) rated Outperform with price target $44 by Wedbush

Posted on: Monday,  Apr 19, 2010  9:25 AM ET by Wedbush

Wedbush rated Outperform PHARMASSET INC. (NASDAQ: VRUS) on 04/19/2010, when the stock price was $15.74. Since
then, PHARMASSET INC. has gained 770.35% as of 01/17/2012's recent price of $136.95.
If you would have followed this Wedbush 's recommendation on VRUS, you would have gained 770.35% of your investment in 638 days.

Pharmasset, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of drugs to treat viral infections. It focuses on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV).

Wedbush is Headquartered in Los Angeles, California with over 90 offices and more than 125 correspondent offices, our commitment to providing relentless, customized service is the foundation of our consistent growth. We deliver superior investment ideas and products through exceptional customer care, financial security, continuity and advanced technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/10/2011 8:25 AM Buy
24.28 28.50
as of 12/31/2010
1 Week up  10.46 %
1 Month up  12.30 %
3 Months up  65.25 %
1 YTD up  17.28 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/2/2010 8:25 AM Buy
20.74 26.00
4/19/2010 9:25 AM Buy
15.74 22.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy